Cargando…

Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives

BACKGROUND: Clinical trials (CTs) are research investigations in which participants receive medical treatments, interventions, or tests to assess their safety and efficacy. Each planned clinical is registered through local or national medical agencies, which may differ in the amount of administrativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanišić, Dragana, Osmanović, Ahmed, Fojnica, Adnan, Kurtović-Kozarić, Amina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254004/
https://www.ncbi.nlm.nih.gov/pubmed/35800034
http://dx.doi.org/10.1016/j.conctc.2022.100953
_version_ 1784740615426146304
author Stanišić, Dragana
Osmanović, Ahmed
Fojnica, Adnan
Kurtović-Kozarić, Amina
author_facet Stanišić, Dragana
Osmanović, Ahmed
Fojnica, Adnan
Kurtović-Kozarić, Amina
author_sort Stanišić, Dragana
collection PubMed
description BACKGROUND: Clinical trials (CTs) are research investigations in which participants receive medical treatments, interventions, or tests to assess their safety and efficacy. Each planned clinical is registered through local or national medical agencies, which may differ in the amount of administrative and legal procedures. The objective of this study was to systematically analyze the registration process for clinical trials in Bosnia and Herzegovina in comparison to other Balkan countries. METHODS: The search strategy was based using two online databases: Clinicaltrials.gov (CTGR) and Cortellis Clinical Trials Intelligence (cTi). Search engines included studies until 26(th) April 2021 and countries were compared in terms of the number of studies, status, type, funding, clinical phases and demographic data. RESULTS: The total number of clinical trials from Bosnia and Herzegovina recorded in the CTGR database was 219, while the cTi database comprised 254 registered studies. The total number of reported clinical trials in CTGR and cTi databases were highest in Serbia (n = 1229, n = 1438), followed by Croatia (n = 1142, n = 1300), and Slovenia (n = 801, n = 948), respectively. However, the highest number of clinical trials per capita is in Slovenia (3.85e-4 in CTGR; 4.56e-4 in cTi), followed by Croatia (2.78e-4 in CTGR; 3.17e-4 in cTi), Serbia (1.41e-4 in CTGR; 1.65e-4 in cTi), and Bosnia and Herzegovina (0.67e-4 CTGR; 0.78e-4 cTi). CONCLUSION: Our analysis showed that Bosnia has the lowest number of clinical trials in the Balkans. Furthermore, the registration process is complex and longer than in developed countries. Since the healthcare system has been in a transition in the past decade, clinical trials are underutilized as a tool for the improvement of patient care. The clinical trial registration process could be improved by establishing an ethical committee at the state level and by enabling a parallel submission process to ethical committees and databases.
format Online
Article
Text
id pubmed-9254004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92540042022-07-06 Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives Stanišić, Dragana Osmanović, Ahmed Fojnica, Adnan Kurtović-Kozarić, Amina Contemp Clin Trials Commun Article BACKGROUND: Clinical trials (CTs) are research investigations in which participants receive medical treatments, interventions, or tests to assess their safety and efficacy. Each planned clinical is registered through local or national medical agencies, which may differ in the amount of administrative and legal procedures. The objective of this study was to systematically analyze the registration process for clinical trials in Bosnia and Herzegovina in comparison to other Balkan countries. METHODS: The search strategy was based using two online databases: Clinicaltrials.gov (CTGR) and Cortellis Clinical Trials Intelligence (cTi). Search engines included studies until 26(th) April 2021 and countries were compared in terms of the number of studies, status, type, funding, clinical phases and demographic data. RESULTS: The total number of clinical trials from Bosnia and Herzegovina recorded in the CTGR database was 219, while the cTi database comprised 254 registered studies. The total number of reported clinical trials in CTGR and cTi databases were highest in Serbia (n = 1229, n = 1438), followed by Croatia (n = 1142, n = 1300), and Slovenia (n = 801, n = 948), respectively. However, the highest number of clinical trials per capita is in Slovenia (3.85e-4 in CTGR; 4.56e-4 in cTi), followed by Croatia (2.78e-4 in CTGR; 3.17e-4 in cTi), Serbia (1.41e-4 in CTGR; 1.65e-4 in cTi), and Bosnia and Herzegovina (0.67e-4 CTGR; 0.78e-4 cTi). CONCLUSION: Our analysis showed that Bosnia has the lowest number of clinical trials in the Balkans. Furthermore, the registration process is complex and longer than in developed countries. Since the healthcare system has been in a transition in the past decade, clinical trials are underutilized as a tool for the improvement of patient care. The clinical trial registration process could be improved by establishing an ethical committee at the state level and by enabling a parallel submission process to ethical committees and databases. Elsevier 2022-06-28 /pmc/articles/PMC9254004/ /pubmed/35800034 http://dx.doi.org/10.1016/j.conctc.2022.100953 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Stanišić, Dragana
Osmanović, Ahmed
Fojnica, Adnan
Kurtović-Kozarić, Amina
Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title_full Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title_fullStr Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title_full_unstemmed Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title_short Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives
title_sort clinical trials in bosnia and herzegovina: challenges and future perspectives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254004/
https://www.ncbi.nlm.nih.gov/pubmed/35800034
http://dx.doi.org/10.1016/j.conctc.2022.100953
work_keys_str_mv AT stanisicdragana clinicaltrialsinbosniaandherzegovinachallengesandfutureperspectives
AT osmanovicahmed clinicaltrialsinbosniaandherzegovinachallengesandfutureperspectives
AT fojnicaadnan clinicaltrialsinbosniaandherzegovinachallengesandfutureperspectives
AT kurtovickozaricamina clinicaltrialsinbosniaandherzegovinachallengesandfutureperspectives